Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, ALL, Lymphoid Leukemias, Biological therapies, Fundamental Science, clinical trials, adult, Translational Research, Non-Biological therapies, Clinical Research, genomics, pediatric, Diseases, Therapies, real-world evidence, Lymphoid Malignancies, Biological Processes, Pharmacology, Technology and Procedures, Study Population, Human, Minimal Residual Disease , Transplantation, molecular testing
Type: Oral
Hematology Disease Topics & Pathways:
Research, ALL, Lymphoid Leukemias, Biological therapies, Fundamental Science, clinical trials, adult, Translational Research, Non-Biological therapies, Clinical Research, genomics, pediatric, Diseases, Therapies, real-world evidence, Lymphoid Malignancies, Biological Processes, Pharmacology, Technology and Procedures, Study Population, Human, Minimal Residual Disease , Transplantation, molecular testing
Monday, December 12, 2022: 10:30 AM-12:00 PM
Great Hall BC
(Ernest N. Morial Convention Center)
Moderators:
Richard Lock, Children's Cancer Research Institute
and
Erin H. Breese, MD, PhD, Cincinnati Children's Hospital Medical Center
Disclosures:
No relevant conflicts of interest to declare.
10:30 AM
10:45 AM
11:15 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH